REVIEW
|
doi:10.20944/preprints202110.0307.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
SARS-Cov-2; COVID-19; oncology; cancer screening; clinical trials
Online: 21 October 2021 (12:45:12 CEST)